Fiera Capital (Canada)
SRPT icon

Fiera Capital (Canada)’s Sarepta Therapeutics SRPT Stock Holding History

Fiera Capital (Canada)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-344,077
Closed -$5.88M – 462
2025
Q2 		$5.88M Sell
344,077
-1,675
-0.5% -$71.5K 0.02% 220
2025
Q1 		$22.1M Sell
345,752
-4,577
-1% -$482K 0.08% 149
2024
Q4 		$42.6M Sell
350,329
-9,667
-3% -$1.18M 0.13% 104
2024
Q3 		$45M Sell
359,996
-22,649
-6% -$3.13M 0.14% 101
2024
Q2 		$60.5M Buy
382,645
+15,606
+4% +$2M 0.19% 77
2024
Q1 		$47.5M Buy
367,039
+18,827
+5% +$2.31M 0.14% 105
2023
Q4 		$33.6M Sell
348,212
-8,111
-2% -$778K 0.1% 119
2023
Q3 		$43.2M Buy
356,323
+73,944
+26% +$8.36M 0.14% 92
2023
Q2 		$32.3M Buy
+282,379
New +$36.4M 0.09% 120

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fiera Capital (Canada)'s SRPT Position: Q3 2025 in Review

Fiera Capital (Canada) sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 344,077 shares — an estimated $5.88M sold.

Fiera Capital (Canada) first reported a position in SRPT in Q2 2023 and held it in 9 quarters. The position peaked at $60.5M in Q2 2024. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Fiera Capital (Canada) reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 344,077 Sarepta Therapeutics shares in Q3 2025, an estimated $5.88M.
  • Fiera Capital (Canada) first reported a position in Sarepta Therapeutics in Q2 2023 and held it in 9 quarters.
  • Fiera Capital (Canada)'s Sarepta Therapeutics position peaked at $60.5M in Q2 2024.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2025, filed 7 Nov 2025.